The cellular immune response plays an important role in protecting against dengue virus in the mouse encephalitis model

Viral Immunology

Volumn 22, Issue 1, 2009, Pages 23-29

  Gil, Lázaro ^a   López, Carlos ^a   Blanco, Aracelys ^a   Lazo, Laura ^a   Martín, Jorge ^a   Valdés, Iris ^a   Romero, Yaremis ^a   Figueroa, Yassel ^a   Guillén, Gerardo ^a   Hermida, Lisset ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI CD8 ANTIBODY; ANTIBODY; BIOLOGICAL MARKER; CD4 ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELL PROTECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DENGUE VIRUS; DEPLETION; ENCEPHALITIS; FEMALE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; SEROTYPE; SPLEEN CELL; STIMULATION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS NEUTRALIZATION;

ANIMALS; ANIMALS, SUCKLING; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENGUE; DENGUE VIRUS; DISEASE MODELS, ANIMAL; ENCEPHALITIS, VIRAL; FEMALE; HUMANS; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C;

ANIMALIA; DENGUE VIRUS; DENGUE VIRUS TYPE 2; MUS;

EID: 60149094510     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2008.0063     Document Type: Article

References (35)

1. Biron CA, and Sen GC: Interferons and other cytokines. In: Fundamental Virology, (Knipe DM, and Howley PM, eds.). Lippincott, Williams & Wilkins, Philadelphia, 2001, pp. 321-351.
2. Brinton MA, and Perelygin AA: Genetic resistance to flaviviruses. Adv Virus Res 2003;60:43-85.
3. Burke DS, Nisalak A, Johnson DE, and Scott RM: A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 1988;38:172-180.
4. Castellino F, and Germain RN: Cooperation between CD4+ and CD8+ T cells: When, Where, and How. Annu Rev Immunol 2006;24:519-540.
5. Cerwenka A, and Lanier LL: Natural killer cells, viruses and cancer. Nat Rev Immunol 2001;1:41-49.
6. Chaturvedi UC, Tandon P, Mathur A, and Kumar A: Host defense mechanism against dengue virus infection of mice. J Gen Virol 1978;39:293-302.
7. Clarke DH, and Casals J: Techniques for hemagglutination and hemagglutination-inhibition with arthropod borne virus. Am J Trop Med Hyg 1958;7:561-573.
8. Gagnon SJ, Zeng W, Kurane I, and Ennis FA: Identification of two epitopes on the dengue 4 capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones. J Virol 1996;70:141-147.
9. Gubler DJ, and Kuno G: Viral pathogenesis of dengue infections. In: Dengue and Dengue Hemorrhagic Fever. (Gubler DJ, and Kuno G, eds.). CAB International, Wallingford, England, 1997, pp. 273-275.
10. Halstead SB: Etiologies of the experimental dengues of Siler and Simmons. Am J Trop Med Hyg 1974;23:974-982.
11. Hawke S, Stevenson PG, Freeman S, and Bangham CR: Long-term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system. J Exp Med 1998;187:1575.
12. Hermida L, Rodríguez R, Lazo L, et al.: A dengue-2 envelope fragment inserted within the structure of the P64k meningococcal protein carrier enables a functional immune response against the virus in mice. J Virol Methods 2004;115:41-49.
13. Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, and Schoenberger SP: CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 2003;421:852-856.
14. Kaufman BM. Summers PL, Dubois DR, and Eckels KH: Monoclonal against dengue-2 virus E glycoprotein protect mice against lethal dengue infection. Am J Trop Med Hyg 1987;36:427.
15. Keating R, Yue W, Rutigliano JA, So J, Olivas E, Thomas PG, and Doherty PC: Virus-specific CD8+ T cells in the liver: armed and ready to kill. J Immunol 2007;178:2737-2745.
16. Kyle JL, Balsitis SJ, Zhang L, Beatty PR, and Harris E: Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model. Virology 2008;380:296-303.
17. Lazo L, Hermida L, Zulueta A, et al.: A recombinant capsid protein from dengue-2 induces protection in mice against homologous virus. Vaccine 2007;25:1064-1070.
18. Lobigs M, Mullbacher A, and Lee E: Evidence that a mechanism for efficient flavivirus budding upregulates MHC class I. Immunol Cell Biol 2004;82:184-188.
19. Marten NW, Stohlman SA, and Bergmann CC: Role of viral persistence in retaining CD8+ T cells within central nervous system. J Virol 2000;74:7903.
20. Masopust D, Kaech SM, Wherry EJ, and Ahmed R: The role of programming in memory T-cell development. Curr Opin Immunol 2004;16:217-225
21. Mongkolsapaya J, Duangchinda T, Dejnirattisai W, et al.: T cell response in dengue hemorrhagic fever: Are cross-reactive T cells suboptimal? J Immunol 2006;176:3821-3829.
22. Morens DM, Halstead SB, and Repik PM: Simplified plaque reduction assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test standard plaque reduction neutralization. J Clin Microbiol 1985;22:250-254.
23. Okuno Y, Fukunaga T, Tadano M, Fuki K, Ikeda T, Sheik K, and Ariyoshi H: Serological studies on volunteers inoculated experimentally with a dengue virus strain in 1943. Biken J 1983;26:161-163.
24. Sabin AB: Research on dengue during World War II. Am J Trop Med Hyg 1952;1:30-50.
25. Schlesinger JJ, Brandis MW, and Walsh EE: Protection of mice against dengue-2 encephalitis by immunization with dengue-2 virus non-structural glycoprotein NS1. J Gen Virol 1987;68:853.
26. Selin LK, Santolucito PA, Pinto AK, Szomolanyi-Tsuda E, and Welsh RM: Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells. J Immunol 2001;166:6784-6794.
27. Shresta S, Kyle JL, Snider HM, Basavapatna M, Beatty PR, and Harris E: Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol 2004;78:2701-2710.
28. Sun JC, and Bevan MJ: Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003;300:339-342.
29. Szomolanyi-Tsuda E, and Welsh RM: T cell-independent antibody-mediated clearance of polyoma virus in T cell deficient mice. J Exp Med 1996;183:403-411.
30. Tscharke DC, and Suhrbier A: From mice to humans - murine intelligence for human CD8+ T cell vaccine design. Expert Opin Biol Ther 2005;5:263-271.
31. Van Der Most RG, Murali-Krishna K, Ahmed R, and Strauss JH: Chimeric yellow fever/ dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response. J Virol 2000;4:8094-8101.
32. Van der Most RG, Murali-Krishna K, and Ahmed R: Prolonged presence of effector-memory CD8 T cells in the central nervous system after dengue virus encephalitis. Intern Immunol 2003;15:119-125.
33. Welsh RM, Selin LK, and Szomolanyi-Tsuda E: Immunological memory to viral infection. Annu Rev Immunol 2004;22:23.1-23.33.
34. Williams MA, Holmes BJ, Sun JC, and Bevan MJ: Developing and maintaining protective CD8+ memory T cells. Immunol Rev 2006;211:146-153.
35. Wu SF, Liao CL, Lin YL, et al.: Evaluation of protective efficacy and immune mechanism of using a non-structural protein NS1 in DNA vaccine against dengue 2 in mice. Vaccine 2003;21:3919-3929.